BCL2 and cancer: According to another in vitro study, esculetin at 55 μg/mL plays a critical role in inhibiting cancer cell viability and inducing apoptosis by increasing Caspase‐3 and ‐9 activation and the level of reactive oxygen species (ROS) and cyt‐C release while decreasing antiapoptotic protein Bcl‐2 expression.42